All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

Harbour offshoot pens $395M biobucks deal for preclinical rival to Neurocrine’s Crenessity

Harbour offshoot pens $395M biobucks deal for preclinic...

Feb 26, 2025  0

GSK plans to move vaccine R&D center from Rockville, Md. to the Boston area

GSK plans to move vaccine R&D center from Rockville, Md...

Feb 12, 2025  0

George Church spinout GRObio explores strategic alternatives 6 months after $60M series B

George Church spinout GRObio explores strategic alterna...

Mar 13, 2025  0